NYSE$CNMD
Conmed Corp. · Q1 2020 earnings
Q1 2020 earnings · · Investor relations
Briefing
CONMED's first quarter results were significantly impacted by the global COVID-19 pandemic, particularly during the second half of the quarter.
CONMED Corporation announced its first quarter 2020 financial results, which were meaningfully impacted by the global COVID-19 pandemic. The company has withdrawn its previously provided 2020 guidance due to the uncertainty created by this evolving dynamic.
- First quarter results were meaningfully impacted by the global COVID-19 pandemic.
- Decisive actions were taken to protect employees and solidify the financial security of the company.
- Management has withdrawn its previously provided 2020 guidance.
- An amendment to the existing credit agreement was announced to provide financial assurance and flexibility.
Headline financials
Revenue & EPS history
Conmed · Revenue · Quarterly
$214M
Revenue by segment
Conmed · $277M total across 2 segments · Q2 2022
- General Surgery$157M—56.6%
- Orthopedic Surgery$120M—43.4%
Forward guidance
Due to the uncertainty created by the evolving COVID-19 dynamic, management has withdrawn its previously provided 2020 guidance and is unable to provide reliable guidance at this time.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2020
-0.0%
Avg return
Earnings day
+0.4%
Avg return
5 days after
+3.0%
Avg return
30 days after
45%
29 / 65 earnings
Positive
+16.5%
Q1 2025
Best reaction
-18.5%
Q3 2015
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.6% | +1.9% | -0.8% | |
| Q4 2025 | -4.0% | +0.3% | +18.9% | |
| Q3 2025 | -0.1% | +0.6% | -9.8% | |
| Q1 2025 | +16.5% | +13.8% | +15.6% | |
| Q4 2024 | -9.0% | -12.1% | -15.2% | |
| Q3 2024 | +5.5% | +9.0% | +14.5% | |
| Q2 2024 | -6.0% | -5.6% | +5.3% | |
| Q1 2024 | -13.2% | -5.7% | +3.9% | |
| Q4 2023 | -11.7% | -13.0% | -15.7% | |
| Q3 2023 | -0.3% | +3.1% | +15.0% | |
| Q2 2023 | -1.6% | +0.8% | -10.1% | |
| Q1 2023 | +11.2% | +9.2% | +2.7% | |
| Q4 2022 | +3.3% | +6.4% | +0.4% | |
| Q3 2022 | -3.3% | -1.0% | +3.2% | |
| Q2 2022 | -2.5% | -4.5% | -10.0% | |
| Q1 2022 | -8.5% | -19.2% | -17.3% | |
| Q4 2021 | +4.9% | +11.0% | +19.6% | |
| Q3 2021 | +1.5% | +2.0% | -5.9% | |
| Q2 2021 | +1.3% | -0.2% | -1.4% | |
| Q1 2021 | +4.8% | +7.0% | +1.5% | |
| Q4 2020 | -4.6% | -6.1% | +3.1% | |
| Q3 2020 | +2.8% | -3.9% | +29.6% | |
| Q2 2020 | +5.5% | -0.4% | +4.8% | |
| Q1 2020 | +9.2% | +0.5% | +8.5% | |
| Q4 2019 | -2.6% | -4.7% | -11.9% | |
| Q3 2019 | +10.4% | +12.9% | +13.7% | |
| Q2 2019 | +7.3% | +4.5% | +15.3% | |
| Q1 2019 | +0.7% | -2.6% | +0.8% | |
| Q4 2018 | +6.1% | +4.9% | +12.8% | |
| Q3 2018 | -0.6% | +1.3% | +0.8% | |
| Q2 2018 | +8.6% | +5.5% | +8.7% | |
| Q1 2018 | +7.2% | +5.3% | +10.7% | |
| Q4 2017 | +10.2% | +7.1% | +6.3% | |
| Q3 2017 | +1.9% | -2.7% | +0.7% | |
| Q2 2017 | -1.3% | +1.3% | -4.1% | |
| Q1 2017 | +4.2% | +6.9% | +7.6% | |
| Q4 2016 | -6.9% | -4.0% | -6.8% | |
| Q3 2016 | +5.0% | +3.3% | +18.3% | |
| Q2 2016 | -17.5% | -16.9% | -17.0% | |
| Q1 2016 | -4.1% | — | — | |
| Q4 2015 | -5.9% | — | — | |
| Q3 2015 | -18.5% | — | — | |
| Q2 2015 | -4.3% | — | — | |
| Q1 2015 | +10.7% | — | — | |
| Q4 2014 | -1.4% | — | — | |
| Q3 2014 | +4.4% | — | — | |
| Q2 2014 | -9.5% | — | — | |
| Q1 2014 | -2.8% | — | — | |
| Q4 2013 | +4.2% | — | — | |
| Q3 2013 | -2.7% | — | — | |
| Q2 2013 | +2.8% | — | — | |
| Q1 2013 | -2.7% | — | — | |
| Q4 2012 | +4.6% | — | — | |
| Q3 2012 | +0.3% | — | — | |
| Q2 2012 | -0.4% | — | — | |
| Q1 2011 | +0.8% | — | — | |
| Q1 2012 | -2.1% | — | — | |
| Q1 2010 | -0.2% | — | — | |
| Q4 2009 | -0.2% | — | — | |
| Q4 2011 | -0.2% | — | — | |
| Q3 2010 | -1.8% | — | — | |
| Q3 2011 | -1.8% | — | — | |
| Q2 2011 | -2.3% | — | — | |
| Q4 2010 | -2.3% | — | — | |
| Q2 2010 | -2.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro